Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -327,658 | -213,898 | -107,370 | -395,893 | -290,574 |
| Depreciation Amortization | 21,535 | 13,538 | 4,719 | 21,609 | 16,556 |
| Income taxes - deferred | -1,720 | -477 | N/A | N/A | N/A |
| Accounts receivable | N/A | -33 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -6,595 | 3,171 | 3,025 | 5,883 | 4,327 |
| Other Working Capital | -18,409 | -24,299 | -12,829 | -2,892 | -5,895 |
| Other Operating Activity | 54,997 | 28,231 | 12,640 | 78,536 | 60,500 |
| Operating Cash Flow | $-277,850 | $-193,767 | $-99,815 | $-292,757 | $-215,086 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 149,250 | 221,310 | 159,060 | 276,880 | 273,397 |
| PPE Investments | -18,761 | -15,184 | -5,664 | -20,425 | -17,403 |
| Net Acquisitions | -212,886 | -209,509 | N/A | N/A | N/A |
| Investing Cash Flow | $-82,397 | $-3,383 | $153,396 | $256,455 | $255,994 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 464,606 | 261,427 | 260,101 | 192,799 | 2,224 |
| Other Financing Activity | -2,609 | -2,230 | -1,929 | -2,649 | -2,649 |
| Financing Cash Flow | $461,997 | $259,197 | $258,172 | $190,150 | $-425 |
| Exchange Rate Effect | -5,761 | -3,768 | N/A | N/A | N/A |
| Beginning Cash Position | 238,161 | 238,161 | 238,161 | 84,313 | 84,313 |
| End Cash Position | 334,150 | 296,440 | 549,914 | 238,161 | 124,796 |
| Net Cash Flow | $95,989 | $58,279 | $311,753 | $153,848 | $40,483 |
| Free Cash Flow | |||||
| Operating Cash Flow | -277,850 | -193,767 | -99,815 | -292,757 | -215,086 |
| Capital Expenditure | -18,761 | -15,184 | -5,664 | -20,425 | -17,403 |
| Free Cash Flow | -296,611 | -208,951 | -105,479 | -313,182 | -232,489 |